open sign - pexels

The EIB Group, comprising of the European investment Bank (EIB) and the European Investment Fund (EIF), has signed an agreement with the Government of Malta and the European Commission to increase financing available under the SME Initiative in Malta.

The reason cited for further funding was the ongoing effects of COVID-19 on Malta’s economy.

The agreement was signed today by Alain Godard, EIF Chief Executive, Miguel Morgado, EIB Director, Stefan Zrinzo Azzopardi, Parliamentary Secretary for EU Funds within the office of the Prime Minister, and Paul Zahra, Permanent Secretary for EU Funds within the Office of the Prime Minister.

The SME Initiative entails the combined use of European Structural and Investment Funds, the Horizon 2020 programme and EIB group funds.

So far, through the SME Initiative in Malta, Bank of Valletta and BNF Bank have assigned a target portfolio of nearly €90 million for new SME financing in the form of loans across the country.

With the successful uptake of this initial agreement in mind, and the pandemic, the Maltese authorities, the EIB Group and the European Commission have decided to add additional resources to this initiative.

This latest agreement will trigger additional €28 million of SMEs financing under advantageous terms, such as reduced interest rates and improved collateral requirements, thus increasing the target portfolio up to EUR 118m.

Malta has contributed up to €29 million from its European Regional Development Fund (ERDF) dedicated envelope. The €29 million will be leveraged with commercial lending through a risk-sharing mechanism.

Related

Valletta

Government achieves surplus but debt grows

March 24, 2023
by Arnas Lasys

Government coffers were boosted by higher revenues from tax income

UBS to buy ailing Credit Suisse in emergency rescue deal

March 20, 2023
by Robert Fenech

The move was welcomed by banking regulators around the world

What does Malta offer the insurance industry?

March 18, 2023
by Robert Fenech

Malta has been at the forefront of the introduction of cell companies in the European Union